Home › Compare › SLROF vs JNJ

SLROF vs JNJ: Dividend Comparison 2026

SLROF yields 13333.33% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SLROF wins by $944051876715324800.00M in total portfolio value
10 years
SLROF
SLROF
● Live price
13333.33%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$944051876715324800.00M
Annual income
$930,326,183,604,330,300,000,000.00
Full SLROF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SLROF vs JNJ

📍 SLROF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLROFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLROF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SLROF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLROF
Annual income on $10K today (after 15% tax)
$1,133,333.33/yr
After 10yr DRIP, annual income (after tax)
$790,777,256,063,680,700,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SLROF beats the other by $790,777,256,063,680,700,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLROF + JNJ for your $10,000?

SLROF: 50%JNJ: 50%
100% JNJ50/50100% SLROF
Portfolio after 10yr
$472025938357662400.00M
Annual income
$465,163,091,802,165,140,000,000.00/yr
Blended yield
98.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SLROF
No analyst data
Altman Z
35.0
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLROF buys
0
JNJ buys
0
No recent congressional trades found for SLROF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLROFJNJ
Forward yield13333.33% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$944051876715324800.00M ✓$20.0K
Annual income after 10y$930,326,183,604,330,300,000,000.00 ✓$827.78
Total dividends collected$943142383073684224.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SLROF vs JNJ ($10,000, DRIP)

YearSLROF PortfolioSLROF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,344,033$1,333,333.33$10,676$355.77+$1.33M → SLROF
2$168,918,905$167,480,789.20$11,407$389.39+$168.91M → SLROF
3$19,852,785,021$19,672,041,793.12$12,198$426.53+$19852.77M → SLROF
4$2,182,013,981,744$2,160,771,501,770.83$13,056$467.62+$2182013.97M → SLROF
5$224,287,824,199,531$221,953,069,239,064.90$13,987$513.12+$224287824.19M → SLROF
6$21,561,870,489,323,890$21,321,882,517,430,390.00$14,998$563.56+$21561870489.31M → SLROF
7$1,938,749,165,623,537,400$1,915,677,964,199,961,300.00$16,098$619.52+$1938749165623.52M → SLROF
8$163,055,200,603,353,700,000$160,980,738,996,136,500,000.00$17,295$681.69+$163055200603353.69M → SLROF
9$12,827,750,571,022,997,000,000$12,653,281,506,377,408,000,000.00$18,599$750.82+$12827750571022998.00M → SLROF
10$944,051,876,715,324,800,000,000$930,326,183,604,330,300,000,000.00$20,022$827.78+$944051876715324800.00M → SLROF

SLROF vs JNJ: Complete Analysis 2026

SLROF — Stock

Stellar Resources Limited, together with its subsidiaries, engages in the exploration of mineral properties in Australia. The company explores for tin and gold deposits. Its flagship project is the Heemskirk Tin project located in northwest Tasmania. The company was incorporated in 2004 and is based in Melbourne, Australia.

Full SLROF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SLROF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLROF vs SCHDSLROF vs JEPISLROF vs OSLROF vs KOSLROF vs MAINSLROF vs ABBVSLROF vs MRKSLROF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.